News

Leichter Wertverlust bei der Centene-Aktie (53,8434 €)
Die Centene-Aktie notiert heute ein wenig leichter. Zuletzt zahlten Investoren für die Aktie 59,96 US-Dollar. Ein Wertverlust in Höhe von 2,91 US-Dollar müssen derzeit die Aktionäre von Centene hinneh ...
Stardust Solar verkauft 5 neue Franchise-Gebiete in Miami, FL an europäischen Investor
Vancouver, British Columbia - (13. Mai 2025) - Stardust Solar Energy Inc. (TSXV: SUN) (OTCQB: SUNXF) (FSE: 6330) ("Stardust Solar" oder das "Unternehmen"), ein führender Franchisegeber für Dienstleist ...
Xtra-Gold Resources Corp.: Xtra-Gold Reports Q1 2025 Financials and CEO Update
Xtra-Gold Resources Corp. (TSX: XTG) (OTCQB: XTGRF) ("Xtra-Gold" or the "Company") is pleased to provide the following summary of the unaudited Financials ...
CNS Pharmaceuticals, Inc.: CNS Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
HOUSTON, TX / ACCESS Newswire / May 13, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for pri ...
Racing Redefined: DP World's Logistics Drive SailGP's 2025 Season
NORTHAMPTON, MA / ACCESS Newswire / May 13, 2025 / DP World:From global doubleheaders to empowering women in sport, DP World's logistics expertise fuels the high-stakes action of SailGP's most ambitio ...
Empress Royalty Corp.: Empress Reports 2025 First Quarter Financial Results
VANCOUVER, BC / ACCESS Newswire / May 13, 2025 / Empress Royalty Corp. (TSXV:EMPR)(OTCQX:EMPYF) ("Empress Royalty" or the "Company") announces financial and operating results for the three months ende ...
VerifyMe, Inc.: VerifyMe Reports First Quarter 2025 Financial Results
Quarterly revenue of $4.5 million, compared to $5.8 million in Q1 2024(1) Quarterly gross profit of $1.5 million or 33%, compared to $2.3 million or 39% in Q1 ...
Atossa Therapeutics Inc: Atossa Therapeutics Announces First Quarter 2025 Financial Results and Provides a Corporate Update
Announced strategic plan to advance (Z)-endoxifen for metastatic breast cancer indication Enhanced (Z)-endoxifen intellectual property portfolio with three new U.S.
Galmed Pharmaceuticals Ltd.: Galmed Reports Significant Anti-Fibrotic Effects of Aramchol in PSC Models
Aramchol, an SCD1 inhibitor, significantly attenuates and prevents biliary fibrosis in mouse models of primary sclerosing cholangitis (PSC) Aramchol treatment leads ...
OptimumBank Holdings Inc.: OptimumBank Holdings, Inc. Financial Performance for the First Quarter of 2025
OptimumBank Holdings, Inc. (NYSE American: OPHC) (the "Company") is a one-bank holding company and owns 100% of OptimumBank (the "Bank"). Today ...
Kohl's Announces Approx. $360 Mln Offering Of Senior Secured Notes
WASHINGTON (dpa-AFX) - Kohl's Corp. (KSS), Tuesday announced offering of approximately $360 million aggregate principal amount of senior secured notes due 2030.The company intends to use the proceeds ...
HireQuest Inc: HireQuest Proposes Acquisition of Trueblue, Inc. for $7.50 per Share
Offers a Significant Premium of 61% to TrueBlue StockholdersHireQuest's High-Margin Franchising Model to drive near-term profitability and enhanced value for shareholders GOOSE CREEK, SC / ACCESS News ...